JAMES DAVID CAMERON: Open Payments
NPI 1447206875 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 53 payments from 20 companies in 2025. Trend: 2023 $265 · 2024 $1,490 · 2025 $1,748
Food & beverage: $1,748
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $348 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $265 |
| Dexcom, Inc. | 3 | $257 |
| AstraZeneca Pharmaceuticals LP | 3 | $163 |
| ABBVIE INC. | 5 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $66 |
| Abbott Laboratories | 2 | $58 |
| Exact Sciences Corporation | 2 | $50 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, Ozempic, Wegovy, UBRELVY, CAPLYTA, SPRAVATO, FREESTYLE LIBRE 3.
Industry payments across WA — which companies pay providers there.
